Angiogenic factor with G-patch and FHA domains 1 pseudogene 7 (AGGF1P7)

AGGF1P7 (Angiogenic factor with G-patch and FHA domains 1 pseudogene 7) is a processed pseudogene found in the human genome and annotated in databases such as NCBI Gene (GeneID: 100132606) and Ensembl (ENSG00000260994)[3][4]. Pseudogenes like AGGF1P7 are genomic loci with high sequence similarity to protein-coding genes but have accumulated mutations (such as premature stop codons or frame shifts) that prevent them from coding functional proteins. While AGGF1P7 specifically has not been described as exerting biological function or being a therapeutic target, certain pseudogenes are known to act via non-coding RNA mechanisms, serving as microRNA decoys (competing endogenous RNAs), thereby regulating the expression of their parental genes or other genes with shared microRNA recognition sites[5]. No evidence in the literature indicates AGGF1P7 is involved in any specific disease, biomarker role, or drug interaction. Key points: - AGGF1P7 is a *pseudogene* and not a receptor, enzyme, transporter, or classical drug target[3][4]. - There are no known drugs, biomarkers, or mechanisms of action associated with AGGF1P7. - Its most likely biological relevance (by analogy to other pseudogenes) would be as a competitive endogenous RNA if transcribed, but no experimental evidence is available for AGGF1P7 specifically[5]. - It is not considered a therapeutic target and is not associated with any direct disease processes. If there is confusion with closely related pseudogenes (such as HMGA1P7, which is transcribed and acts as a competing endogenous RNA in cancer), this should be carefully checked, but AGGF1P7 itself is correctly identified and described here[3][4].

Other names

AGGF1P7